Multiple Sclerosis NZ share latest information on COVID-19 and MS relevant to New Zealand.
The advice on MSNZ website has been developed with the support of MS clinicians, research experts and international advice. It is based on the emerging evidence of how COVID-19 affects people with multiple sclerosis (MS) and expert opinion. This advice will be reviewed and updated as further evidence about COVID-19 and SARS-CoV-2 becomes available. The information is specific to an NZ audience so does not cover all the vaccines and DMTs available globally, only what is available in NZ.
